Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from GSK

FTSE 100 Live 1 May: US Fed notes ‘lack of further progress’ on inflation as it holds interest rates

Forecast-beating results by Shell and Standard Chartered today boosted their shares during another robust session for the FTSE 100 index.

Evening Standard

Asthma Medication Shortage Puts Children At Risk

Families face challenges in affording essential asthma medication for children due to high costs and limited insurance coverage, highlighting the need for ...

Top News

Sanofi To Settle Around 4,000 Suits Over Zantac Cancer Allegations

Sanofi will settle around 4,000 claims alleging its heartburn medication, Zantac, is linked to cancer.

International Business Times

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Pharma Stocks Fueling Investor Enthusiasm

The pharmaceutical industry is expected to expand rapidly due to growing global healthcare needs and advancements in technology. Therefore, fundamentally strong pharma stocks Merck (MRK), AbbVie (ABBV), and GSK plc (GSK) might be ideal additions to your portfolio. Read on.

StockNews.com

Beyond the GRANOLAS: JPMorgan Picks 3 Top Stocks to Bet on Europe

The renowned brokerage firm weighed in on its top stock picks from the European market, which could offer investors better value than the outsized GRANOLAS group of equities at current levels.

Barchart

‘It feels like we’ve been lobotomised’: the possible sexual consequences of SSRIs

Long-term sexual dysfunction is a side-effect for some patients who take these widely prescribed antidepressants, and can leave sufferers devastated

The Guardian - UK

GlaxoSmithKline boss’s pay package jumps 50% to £12.7m

Emma Walmsley’s deal, with a high share bonus payout, makes her one of top-paid CEOs in FTSE 100

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

GSK Settles California Lawsuit On Zantac Heartburn Drug

GSK reaches settlement in California lawsuit related to Zantac amidst ongoing legal challenges over cancer risks.

Top News

3 Pharma Stocks to Anchor Your Portfolio

The pharma market is poised to thrive due to the continuous medicinal advancements to meet the escalating demand for chronic disease treatment, technological advancements, and increased research and development. Given this backdrop, quality pharma stocks Procaps Group S.A. (PROC), Supernus Pharmaceuticals (SUPN), and GSK plc (GSK) could be wise portfolio…

StockNews.com

30 Most Powerful Women In Business: The Titans Of Industry

Here are the women, who are forging paths and breaking barriers across industries, showcasing exceptional leadership and innovation.

International Business Times

GSK’s Julie Brown to join drinks giant Diageo’s board

Guinness and Smirnoff vodka maker Diageo has appointed Julie Brown as a non-executive director with effect from August 5.

Evening Standard

1 Pharma Stock to Buy Near 52-Week Highs

GSK's stock has been a poor performer for years. But recently, the pharma stock keeps setting new 52-week highs, thanks to its blockbuster vaccines.

Barchart

Unleash Gain Potential With 3 Pharma Stocks to Consider

With an increasing demand for treatments of chronic diseases, heightened investments in research and development, and the widespread integration of technology, the pharma industry is primed for success. Amid the solid industry prospects, let’s analyze the gain potential of three pharma stocks: Amneal Pharmaceuticals (AMRX), AbbVie Inc. (ABBV), and GSK…

StockNews.com

Arm becomes Britain's sixth most valuable company after shares rise 50%

FTSE stalwarts BP, GSK and Diageo have been left in the dust by the UK’s biggest Nasdaq-listed firm

Evening Standard

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Top 3 Smart Pharma Picks for Good Investments

As global medical needs and technology evolve, the pharmaceutical industry is expected to thrive. Therefore, fundamentally strong pharma stocks Eli Lilly (LLY), AstraZeneca (AZN) and GSK (GSK) might be ideal additions to your portfolio. Read on.

The Guardian - UK

Obesity drug boom pushes Novo Nordisk shares to record high

Market value of Danish drugmaker behind Wegovy and Ozempic tops $500bn as demand soars

Evening Standard

FTSE 100 Live 31 January: US Fed holds rates, London index closes down after late slide

The property market’s new year resilience and upgraded GSK targets are in focus ahead of tonight's US interest rates decision.

Top News

GSK surpasses Q4 estimates, projects 2024 growth

GSK's fourth-quarter results exceeded expectations, signaling company growth in 2024. Learn more about the positive financial outlook for GSK.

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily

More Than 150 Infants, Pregnant Women Given Incorrect RSV Vaccine, CDC Says

According to reports, there have been 25 cases of accidental administration of Pfizer (Abrsyvo) or GSK (Arexvy) RSV vaccines to children below two and 128 cases of mistaken administration of the GSK RSV vaccine (Arexvy) to pregnant women.

International Business Times

Economic Outlook Keeps Investors Wary On Nigeria

Record inflation, a sliding naira currency and weak financial structure are keeping investors wary of Nigeria, Africa's largest economy, with some companies even stepping away despite economic reforms under recently-elected President Bola Ahmed Tinubu.

StockNews.com

3 A-Rated Medical Stocks to Watch and Buy

The medical industry is set for significant growth due to technological advances, increased demand for medicines due to an aging population, escalating healthcare costs, and the rising need for quality healthcare. Therefore, it could be wise to buy fundamentally strong medical stocks GSK (GSK), National HealthCare (NHC), and MiMedx Group…

Top News

GSK Supercharges Respiratory Line with GSK Supercharges Respiratory Line with Top News.4B Aiolos Bio Acquisition.4B Aiolos Bio Acquisition

GSK breathes new life into respiratory portfolio with the acquisition of Aiolos Bio in an impressive GSK Supercharges Respiratory Line with Top News.4B Aiolos Bio Acquisition.4 billion deal. Innovation keeps us breathing easy!

WEKU

Flovent — a common asthma inhaler — will be discontinued in 2024. There will be a generic version available, but the change could make it hard for some patients to get their medication.

Top News

GSK Slashes US Prices for Advair, Valtrex, Lamictal

GSK, the pharmaceutical giant, is taking a bold step by announcing price reductions for popular drugs Advair, Valtrex, and Lamictal in the US. A refreshing...

The Guardian - UK

AstraZeneca buys US vaccine company in $1.1bn deal

Britain’s biggest drugmaker acquires Seattle-based firm Icosavax, expanding vaccine and immune therapy business

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.